search icon
bglc-img

BioNexus Gene Lab Corp Common stock, Common Stock

BGLC

NAQ

$2.94

+$0.11

(3.89%)

1D
Industry: Chemicals Sector: Materials

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.12M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
16.26K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.72
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.01 L
$7.5 H
$2.94

About BioNexus Gene Lab Corp Common stock, Common Stock

BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It also develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia. more

Industry: ChemicalsSector: Materials

Returns

Time FrameBGLCSectorS&P500
1-Week Return3.16%-1.55%-1.87%
1-Month Return1.73%5.18%8.93%
3-Month Return-18.33%-2.58%-2.39%
6-Month Return17.6%-9.85%-2.41%
1-Year Return-45.96%-5.38%10.88%
3-Year Return-98.37%2.11%46.93%
5-Year Return73400%57.59%94.89%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue11.39M13.36M10.93M9.77M9.51M[{"date":"2020-12-31","value":85.24,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.79,"profit":true},{"date":"2023-12-31","value":73.12,"profit":true},{"date":"2024-12-31","value":71.17,"profit":true}]
Cost of Revenue9.67M11.17M9.67M8.44M8.22M[{"date":"2020-12-31","value":86.59,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":86.58,"profit":true},{"date":"2023-12-31","value":75.58,"profit":true},{"date":"2024-12-31","value":73.61,"profit":true}]
Gross Profit1.72M2.19M1.26M1.33M1.29M[{"date":"2020-12-31","value":78.39,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":57.39,"profit":true},{"date":"2023-12-31","value":60.6,"profit":true},{"date":"2024-12-31","value":58.78,"profit":true}]
Gross Margin15.10%16.42%11.52%13.61%13.56%[{"date":"2020-12-31","value":91.97,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":70.17,"profit":true},{"date":"2023-12-31","value":82.88,"profit":true},{"date":"2024-12-31","value":82.59,"profit":true}]
Operating Expenses446.00K1.14M1.55M3.92M2.86M[{"date":"2020-12-31","value":11.37,"profit":true},{"date":"2021-12-31","value":29.01,"profit":true},{"date":"2022-12-31","value":39.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":72.98,"profit":true}]
Operating Income1.27M1.06M(291.18K)(2.59M)(1.57M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":82.89,"profit":true},{"date":"2022-12-31","value":-22.86,"profit":false},{"date":"2023-12-31","value":-203.61,"profit":false},{"date":"2024-12-31","value":-123.54,"profit":false}]
Total Non-Operating Income/Expense(22.63K)(25.95K)(24.96K)(28.44K)105.35K[{"date":"2020-12-31","value":-21.48,"profit":false},{"date":"2021-12-31","value":-24.63,"profit":false},{"date":"2022-12-31","value":-23.69,"profit":false},{"date":"2023-12-31","value":-26.99,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income1.26M1.04M(303.66K)(2.61M)(1.59M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":82.6,"profit":true},{"date":"2022-12-31","value":-24.05,"profit":false},{"date":"2023-12-31","value":-206.53,"profit":false},{"date":"2024-12-31","value":-126.32,"profit":false}]
Income Taxes168.41K291.28K52.31K21.53K3.49K[{"date":"2020-12-31","value":57.82,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":17.96,"profit":true},{"date":"2023-12-31","value":7.39,"profit":true},{"date":"2024-12-31","value":1.2,"profit":true}]
Income After Taxes1.09M751.57K(355.97K)(2.63M)(1.60M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":68.69,"profit":true},{"date":"2022-12-31","value":-32.54,"profit":false},{"date":"2023-12-31","value":-240.29,"profit":false},{"date":"2024-12-31","value":-146.09,"profit":false}]
Income From Continuous Operations1.42M795.14K(355.97K)(3.09M)(1.60M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":55.86,"profit":true},{"date":"2022-12-31","value":-25.01,"profit":false},{"date":"2023-12-31","value":-217.33,"profit":false},{"date":"2024-12-31","value":-112.29,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income1.09M751.57K(355.97K)(2.63M)(1.60M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":68.69,"profit":true},{"date":"2022-12-31","value":-32.54,"profit":false},{"date":"2023-12-31","value":-240.29,"profit":false},{"date":"2024-12-31","value":-146.09,"profit":false}]
EPS (Diluted)0.020.27(0.25)(1.61)(0.89)[{"date":"2020-12-31","value":6.01,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-90.86,"profit":false},{"date":"2023-12-31","value":-592.37,"profit":false},{"date":"2024-12-31","value":-327.45,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BGLC
Cash Ratio 0.70
Current Ratio 4.19
Quick Ratio 3.44

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BGLC
ROA (LTM) -10.86%
ROE (LTM) -17.78%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BGLC
Debt Ratio Lower is generally better. Negative is bad. 0.18
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.82

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BGLC
Trailing PE NM
Forward PE NM
P/S (TTM) 0.56
P/B 0.68
Price/FCF NM
EV/R 0.20
EV/Ebitda 629.53

FAQs

What is BioNexus Gene Lab Corp Common stock share price today?

BioNexus Gene Lab Corp Common stock (BGLC) share price today is $2.94

Can Indians buy BioNexus Gene Lab Corp Common stock shares?

Yes, Indians can buy shares of BioNexus Gene Lab Corp Common stock (BGLC) on Vested. To buy BioNexus Gene Lab Corp Common stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BGLC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of BioNexus Gene Lab Corp Common stock be purchased?

Yes, you can purchase fractional shares of BioNexus Gene Lab Corp Common stock (BGLC) via the Vested app. You can start investing in BioNexus Gene Lab Corp Common stock (BGLC) with a minimum investment of $1.

How to invest in BioNexus Gene Lab Corp Common stock shares from India?

You can invest in shares of BioNexus Gene Lab Corp Common stock (BGLC) via Vested in three simple steps:

  • Click on Sign Up or Invest in BGLC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in BioNexus Gene Lab Corp Common stock shares
What is BioNexus Gene Lab Corp Common stock 52-week high and low stock price?

The 52-week high price of BioNexus Gene Lab Corp Common stock (BGLC) is $7.5. The 52-week low price of BioNexus Gene Lab Corp Common stock (BGLC) is $2.01.

What is BioNexus Gene Lab Corp Common stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of BioNexus Gene Lab Corp Common stock (BGLC) is 0.68

What is the Market Cap of BioNexus Gene Lab Corp Common stock?

The market capitalization of BioNexus Gene Lab Corp Common stock (BGLC) is $5.12M

What is BioNexus Gene Lab Corp Common stock’s stock symbol?

The stock symbol (or ticker) of BioNexus Gene Lab Corp Common stock is BGLC

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top